Selective Insurance (SIGI) Q4 2025 earnings review
The Bleeding Stops: Casualty Reserves Stabilize, ROE Hits 18%
After a year plagued by 'social inflation' and reserve charges, Selective delivered a clean Q4 2025. The headline story is stability: prior-year casualty reserve development was zero (flat), a massive pivot from the $100M charge in the year-ago quarter. With the underwriting noise silenced, the earnings engine roared to life. Net Income surged 64% YoY to $152.9M, driven by a 93.8% Combined Ratio and a 17% jump in Investment Income. While growth is decelerating (Net Premiums Written +4%) due to deliberate shrinking in Personal Lines, the profitability restoration is real.
🐂 Bull Case
For the first time in recent quarters, there was no net unfavorable prior-year casualty reserve development (vs. $100M unfavorable in 24Q4). Standard Commercial Lines actually saw $1.6M favorable development, suggesting recent aggressive loss picks were sufficient.
Net Investment Income rose 17% YoY to $114M. With a fixed income portfolio yield of 4.1% (after-tax) and guidance for $465M in FY26 (up ~10% vs FY25), this provides a high floor for ROE regardless of underwriting volatility.
🐻 Bear Case
Standard Personal Lines is a drag on results. The Combined Ratio deteriorated to 103.0% (unprofitable) from 91.7% a year ago, driven by higher auto severity and catastrophe losses. The company is shrinking this book (-8% premiums), but it remains a margin headwind.
Top-line growth has slowed to 4% (down from double digits in prior years). Renewal pricing power is slightly fading (8.3% vs 9.5% full-year average), and retention is under pressure as the company prioritizes margin over volume.
⚖️ Verdict: 🟢
Bullish. The thesis for SIGI was 'wait for the reserves to stabilize.' That happened this quarter. With an 18% ROE, book value up 18% YoY, and the reserve overhang clearing, the stock warrants a higher multiple despite slowing top-line growth.
Key Themes
The End of the Reserve Drag?
In 2024 and mid-2025, Selective was hammered by 'social inflation' charges. Q4 2025 marks a decisive break in that trend. Net prior year casualty reserve development was $0.0M. Specifically, Standard Commercial—the core engine—swung to favorable development (-$1.6M) from an $8.5M charge a year ago. If this stability holds, the valuation discount applied to SIGI should narrow.
Investment Income Engine
Accelerating. High interest rates continue to flow through the portfolio. After-tax Net Investment Income hit $114.2M (+17% YoY), generating 13.6 points of ROE on its own. FY26 guidance ($465M) implies this tailwind persists, providing a massive safety net for earnings.
Personal Lines Contraction & Losses
Reversing to Negative. Standard Personal Lines (8% of NPW) is in trouble. Premiums shrank 8% YoY as the company deliberately shed business to fix profitability. However, the Combined Ratio worsened to 103.0% (loss-making) due to higher auto severity and catastrophe losses. New business plummeted 18%. This segment is shrinking but bleeding.
Standard Commercial Profitability
Standard Commercial (78% of premiums) is the star. The Combined Ratio improved by 7.3 points to 92.9%. This was driven by solid pricing (+7.5% renewal pure price) and the absence of the reserve charges that plagued the prior year. If Commercial stays in the low-90s, SIGI is a compounder.
Pricing vs. Retention Tension
Pricing remains strong but is decelerating. Renewal pure price increase was 8.3%, down from 10.7% a year ago. While still healthy, retention in Personal Lines dropped (80%) and new business is down. The company is successfully trading volume for margin, but the 'easy' pricing gains may be in the rearview mirror.
Other KPIs
Accelerating. Up 18% YoY ($47.99 to $56.74). This was driven by strong earnings ($7.49 EPS) and a $3.01 benefit from lower unrealized losses on fixed income securities as rates stabilized/dropped. Valuation looks attractive relative to this growth.
Stable. The E&S segment continues to perform well with a 93.1% combined ratio (flat YoY) and +4% growth. While not the 20%+ growth seen in previous years, it remains a profitable steady contributor.
Accelerating. Up significantly from 13.5% in 24Q4 and the 10-year average of 12.1%. This demonstrates the earnings power of the model when underwriting is clean (sub-94 combined ratio) combined with the current investment yield environment.
Guidance
Stable. The midpoint (97.0%) is essentially in line with FY25 actuals (97.2%). This guidance includes 6 points of catastrophe losses and explicitly assumes *zero* prior year casualty reserve development. It suggests management believes the underwriting improvements are sustainable but isn't promising a return to low-90s yet.
Accelerating. Implies ~10.4% YoY growth vs FY25 ($421.2M). This is the most reliable profit driver for the next 12 months.
Stable. Consistent with FY25 actuals (20.7%) and statutory rates.
Key Questions
Confidence in Reserve Stability
Q4 showed zero net casualty reserve development, a stark contrast to the prior three quarters. Can you detail what specifically changed in the actuarial data (paid vs incurred) for the 2024/2025 accident years that gave you confidence to stop strengthening reserves?
Personal Lines Trajectory
Standard Personal Lines combined ratio deteriorated to 103% despite shrinking the book by 8%. At what point does the 'profit improvement' strategy yield a sub-100 combined ratio, or is this segment structurally challenged in your current footprint?
Growth vs. Pricing
Renewal pricing decelerated to 8.3% from 10.7% last year, and overall NPW growth slowed to 4%. As inflation moderates, do you see pricing power eroding further in 2026, and will you pivot back to volume growth if margins hold?
Capital Allocation
With an 18% ROE and shares trading near book value, repurchases were only $30M in the quarter. Given the strong capital generation, why not be more aggressive with buybacks?